Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.150
-0.005 (-0.12%)
Jan 29, 2026, 1:47 PM EST - Market open
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $157.11 million as of January 29, 2026. Its market cap has decreased by -13.96% in one year.
Market Cap
157.11M
Enterprise Value
22.96M
1-Year Change
-13.96%
Ranking
Category
Stock Price
$4.15
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $157.11M, a decrease of -73.62%. That is a compound annual growth rate of -15.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 148.99M | -6.96% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 159.74M |
| Vaxart | 157.22M |
| Tenaya Therapeutics | 152.85M |
| Unicycive Therapeutics | 147.86M |
| Turn Therapeutics | 146.05M |
| Black Diamond Therapeutics | 145.86M |
| Connect Biopharma Holdings | 145.35M |
| Elicio Therapeutics | 144.34M |